01 Economic Incentives by Various GovernmentsGovernments worldwide offer financial assistance with economic incentives to private vaccine storage equipment businesses. Due to the high cost of manufacturing vaccine storage equipment, businesses are encouraged to invest in developing cutting-edge and environmentally friendly goods through financial incentives like tax credits, grants, infrastructure assistance, no-interest financing, free land, and tax reductions. In 2019, the Thai Government allowed companies to claim deductions of up to 1.25 times for expenses if they buy vaccine storage equipment between January 2019 and Dec 31, 2021. These tax measures were expected to attract 10% of existing plastics entrepreneurs to change production to bio-plastics.Similarly, the Kenyan government also plans to grant tax breaks to promote the production of alternative packaging made of plastic. Besides, by assisting with incentives, the government will also receive investment returns from environmental and economic impacts. This, in turn, will act as a positive factor driving the growth of the vaccine storage equipment industry.
02 Enforcement of Environment Protection RulesSeveral governments worldwide have become increasingly concerned about packaging waste and resource use in recent years. The growing environmental concerns due to the increasing waste accumulation and plastic pollution has led to the implementation of rules and regulation to protect the environment and create sustainability in the environment. These laws are reducing packaging waste and resources more efficiently.Furthermore, the government ban on non-biodegradable packaging materials such as pouches and sachets is favoring the growth of packaging materials such as biodegradable plastics in the market. In the U.S., government organizations such as the Environmental Protection Agency, the U.S. Federal Trade Commission, and European, the U.S. Regulation of Solid Waste Disposal, and several others have imposed regulations for reducing plastic packaging waste. This regulation has increased the demand for packaging systems that provides enormous commercial and environmental potential, which in turn, boosts the growth of the vaccine storage equipment market.
01 High Cost of Vaccine Storage Equipment Compared to Traditional Plastic Packaging ProductsVaccine storage equipment materials are made from renewable raw materials and petrochemicals with biodegradable additives that enhance biodegradation. However, the price of the raw materials and production methods required for the vaccine storage equipment is high. This adds to the additional cost of the product and makes it expensive. Biodegradable bags made from corn or potato starches can cost as much as ten times as traditional plastic bags. Furthermore, the cost of research and development still makes up for a share of investment in vaccine storage equipment and impacts material and product prices. Therefore, the production of biodegradable plastics requires more investment, thereby restraining market growth.
01 Global Corporations Adopting Eco-Friendly Packaging Due to Changing Consumer TrendsConsumer demand for greener products and reduced packaging has also increased. Research from the Center for Sustainable Business (CIB) has found that consumers are purchasing more sustainability-marketed products and are making efforts to reduce their plastic footprint due to the growing awareness regarding the harmful environmental effects of plastic. They are also paying more attention to their purchasing decisions regarding packaging, and many are changing their shopping habits.Further, due to these changing consumer trends worldwide, several brands and global corporations are also switching to eco-friendly packaging. For instance, McDonald's claims that by 2025, 100% of its guest packaging will be made from sustainable, recycled, or approved sources. Therefore, businesses will increasingly look to innovators in the vaccine storage equipment sector that create feasible, affordable, and scalable packaging alternatives to conventional materials, which will develop profitable opportunities for the players operating in the vaccine storage equipment category over the forecast years.
June 2026 WHO expanded its immunization cold chain support initiatives by updating tools and resources for vaccine storage equipment management, including temperature monitoring and cold chain equipment assessment frameworks. The initiative supported healthcare systems in improving vaccine storage reliability, equipment planning, and supply chain performance, encouraging adoption of advanced monitoring-enabled storage solutions.
April 2026 Haier Biomedical continued expanding its vaccine cold chain technology portfolio through development of intelligent refrigeration systems and digital monitoring solutions. The company focused on improving vaccine storage efficiency through IoT-enabled equipment, remote temperature management, and energy-efficient refrigeration technologies for healthcare facilities.
March 2026 Thermo Fisher Scientific advanced its laboratory and healthcare cold storage solutions through continued product innovation focused on temperature-sensitive biological materials. The company continued strengthening refrigeration and ultra-low temperature storage technologies supporting vaccine research, development, and healthcare applications.
February 2026 Panasonic Healthcare expanded its medical refrigeration technology initiatives by focusing on reliable cold chain solutions for pharmaceutical and vaccine storage applications. The company continued improving storage systems with enhanced temperature stability, monitoring capabilities, and operational efficiency for healthcare providers.